See more : Star Royalties Ltd. (STRR.V) Income Statement Analysis – Financial Results
Complete financial analysis of Alternate Health Corp. (AHGIF) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Alternate Health Corp., a leading company in the Medical – Healthcare Information Services industry within the Healthcare sector.
- Nippon Densetsu Kogyo Co., Ltd. (1950.T) Income Statement Analysis – Financial Results
- KTBST Mixed Freehold and Leasehold Real Estate Investment Trust (KTBSTMR.BK) Income Statement Analysis – Financial Results
- Bank Norwegian Asa (BANO.OL) Income Statement Analysis – Financial Results
- Argo Living Soils Corp. (ARGO.CN) Income Statement Analysis – Financial Results
- AS ONE Corporation (7476.T) Income Statement Analysis – Financial Results
Alternate Health Corp. (AHGIF)
Industry: Medical - Healthcare Information Services
Sector: Healthcare
Website: https://www.alternatehealth.com
About Alternate Health Corp.
Alternate Health Corp., a diversified healthcare company, provides cloud based software solutions in Canada. It offers medical practice and controlled substance management software, blood analysis and toxicology labs, clinical research, continuing education programs, nutraceutical products, and security and control services to the medical cannabis industry. The company is headquartered in Toronto, Canada.
Metric | 2018 | 2017 | 2016 | 2015 | 2014 |
---|---|---|---|---|---|
Revenue | 577.17K | 13.25M | 183.55K | 167.56K | 0.00 |
Cost of Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Gross Profit | 577.17K | 13.25M | 183.55K | 167.56K | 0.00 |
Gross Profit Ratio | 100.00% | 100.00% | 100.00% | 100.00% | 0.00% |
Research & Development | 484.94K | 506.88K | 0.00 | 0.00 | 0.00 |
General & Administrative | 13.93M | 26.05M | 1.49M | 21.48K | 0.00 |
Selling & Marketing | 264.66K | 284.90K | 13.43K | 0.00 | 0.00 |
SG&A | 14.19M | 26.34M | 1.50M | 21.48K | 0.00 |
Other Expenses | 0.00 | -493.10K | -752.79K | 0.00 | 0.00 |
Operating Expenses | 17.25M | 43.91M | 1.59M | 21.48K | 0.00 |
Cost & Expenses | 17.25M | 43.91M | 1.59M | 21.48K | 0.00 |
Interest Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Interest Expense | 542.18K | 92.90K | 70.40K | 269.00 | 0.00 |
Depreciation & Amortization | 1.13M | 1.37M | 96.10K | 269.00 | 0.00 |
EBITDA | -15.74M | -27.18M | -1.32M | -131.61K | 0.00 |
EBITDA Ratio | -2,727.81% | -222.38% | -716.52% | -12.82% | 0.00% |
Operating Income | -16.88M | -18.52M | -1.41M | -21.75K | 0.00 |
Operating Income Ratio | -2,923.85% | -139.76% | -768.88% | -12.98% | 0.00% |
Total Other Income/Expenses | -7.11M | -10.12M | -860.24K | -28.46K | 0.00 |
Income Before Tax | -23.99M | -28.64M | -2.18M | -21.75K | 0.00 |
Income Before Tax Ratio | -4,156.17% | -216.11% | -1,190.15% | -12.98% | 0.00% |
Income Tax Expense | 337.07K | -2.51M | -431.22K | 269.00 | 0.00 |
Net Income | -23.99M | -26.13M | -1.75M | -21.75K | 0.00 |
Net Income Ratio | -4,156.17% | -197.17% | -955.21% | -12.98% | 0.00% |
EPS | -0.44 | -0.53 | -0.03 | 0.00 | 0.00 |
EPS Diluted | -0.44 | -0.53 | -0.03 | 0.00 | 0.00 |
Weighted Avg Shares Out | 54.16M | 49.75M | 51.87M | 29.48M | 0.00 |
Weighted Avg Shares Out (Dil) | 54.16M | 49.75M | 51.87M | 29.48M | 0.00 |
Source: https://incomestatements.info
Category: Stock Reports